These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7003801)

  • 21. Prostacyclin in cardiopulmonary bypass operations.
    Faichney A; Davidson KG; Wheatley DJ; Davidson JF; Walker ID
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):601-8. PubMed ID: 6750247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass.
    Aren C; Feddersen K; Rådegran K
    Ann Thorac Surg; 1983 Jul; 36(1):49-54. PubMed ID: 6222712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of prostacyclin infusion given before and during cardiopulmonary bypass to assess the first pass effect of the circuit on platelet number and function.
    Jestice HK; Humphreys JE; English TA; Hoggarth CE; Wells FC
    Eur J Cardiothorac Surg; 1990; 4(1):40-4. PubMed ID: 2106334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of prostaglandin I2 infusion during experimental cardiopulmonary bypass (author's transl)].
    Matsukura H; Takeda H; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Feb; 30(2):164-71. PubMed ID: 7047654
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of prostacyclin in regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1980; 17():318-22. PubMed ID: 7017677
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery.
    Greeley WJ; Bushman GA; Kong DL; Oldham HN; Peterson MB
    J Thorac Cardiovasc Surg; 1988 May; 95(5):842-9. PubMed ID: 3283461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of coronary arterial prostacyclin infusion.
    Hall RJ; Dewar HA
    Lancet; 1981 Apr; 1(8226):949. PubMed ID: 6112358
    [No Abstract]   [Full Text] [Related]  

  • 29. [1st intravenous administration of prostacyclin to man].
    Szczeklik A; Gryglewski R; Nizankowski R; Musiał J; Serwońska M; Pietoń R; Mruk J
    Pol Tyg Lek; 1978 Sep; 33(36):1405-8. PubMed ID: 360190
    [No Abstract]   [Full Text] [Related]  

  • 30. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatosensory evoked potentials and cerebral metabolism during cardiopulmonary bypass with special reference to hypotension induced by prostacyclin infusion.
    Arén C; Badr G; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):73-9. PubMed ID: 3925243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of ischemic acute tubular necrosis with tris buffer or prostacyclin infusion.
    Isenberg GA; Hasday K; Oh J; Racelis D; Shapira Z; Schanzer H
    Mt Sinai J Med; 1981; 48(2):142-5. PubMed ID: 7012599
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention by a stable prostacyclin analogue, 7-oxoprostaglandin I2 of the platelet loss during experimental cardiopulmonary bypass.
    Juhász-Nagy S; Kékesi V; Sótonyi P; Moravcsik G; Kovács G
    Acta Chir Hung; 1988; 29(3):251-61. PubMed ID: 3071058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
    Addonizio VP; Fisher CA; Bowen JC; Palatianos GC; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1981; 27():304-7. PubMed ID: 7036500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prostacyclin infusion on active and inactive renin release in the isolated perfused kidney.
    Ohde H; Ogihara T; Nakamaru M; Higaki J; Gotoh S; Masuo K; Ohtsuka A; Saeki S; Kumahara Y
    Life Sci; 1982 Dec; 31(26):3031-5. PubMed ID: 6761534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ischaemic stroke with prostacyclin.
    Gryglewski RJ; Nowak S; Kostka-Trabka E; Kusmiderski J; Dembinska-Kiec A; Bieron K; Basista M; Blaszczyk B
    Stroke; 1983; 14(2):197-202. PubMed ID: 6340253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous prostacyclin in thrombotic thrombocytopenic purpura.
    Fitzgerald GA; Maas RL; Stein R; Oates JA; Roberts LJ
    Ann Intern Med; 1981 Sep; 95(3):319-22. PubMed ID: 7023309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.